Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 9.77%
March 31, 2026 5.18%
December 31, 2025 6.35%
September 30, 2025 7.69%
June 30, 2025 7.32%
March 31, 2025 5.18%
December 31, 2024 4.24%
September 30, 2024 4.57%
June 30, 2024 1.36%
March 31, 2024 1.37%
December 31, 2023 4.42%
September 30, 2023 5.66%
June 30, 2023 4.57%
March 31, 2023 0.83%
March 31, 2021 12.74%
December 31, 2020 12.33%
September 30, 2020 21.12%
June 30, 2020 4.20%
March 31, 2020 15.74%
December 31, 2019 14.86%
September 30, 2019 11.55%
June 30, 2019 14.24%
March 31, 2019 9.88%
December 31, 2018 10.46%
September 30, 2018 12.99%
Date Value
June 30, 2018 15.95%
March 31, 2018 13.97%
December 31, 2017 21.59%
September 30, 2017 14.50%
June 30, 2017 12.70%
March 31, 2017 12.60%
December 31, 2016 12.66%
September 30, 2016 14.14%
June 30, 2016 14.03%
March 31, 2016 13.02%
December 31, 2015 12.32%
September 30, 2015 14.41%
June 30, 2015 13.38%
March 31, 2015 14.07%
December 31, 2014 14.24%
September 30, 2014 13.72%
June 30, 2014 12.71%
March 31, 2014 14.99%
December 31, 2013 11.24%
September 30, 2013 12.54%
June 30, 2013 13.04%
March 31, 2013 13.10%
December 31, 2012 8.96%
September 30, 2012 9.75%
June 30, 2012 10.14%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
argenx SE --
Evaxion AS --
Akari Therapeutics Plc --
Pharma Mar SA -1.96%
Oryzon Genomics SA --